| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |